Process for typing of HCV isolates

Details Process for typing of HCV isolates Process for typing of HCV isolates

2007-08-21

2007-08-21

Whisenant, Ethan (Department: 1634)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving nucleic acid

C536S023100, C536S024300

Reexamination Certificate

active

10822711

ABSTRACT:
The invention relates to a process for genotyping any HCV isolate present in a biological sample, previously identified as being HCV positive, and for classifying said isolate according to the percentage of homology with other HCV isolates, comprising the steps of:contacting said sample in which the ribonucleotides or deoxyribonucleotides have been made accessible, if need be, under suitable denaturation, with at least one probe from about 10 to about 40 nucleotides, with said probe being liable to hybridize to a region being in the domain extending from nucleotide at position −291 to nucleotide at position −66 of the 5′ untranslated region of one of the HCV isolates represented by their cDNA sequences, with said numbering of position beginning with the first ATG codon of the open reading frame encoding the HCV polyprotein, or with said probe being complementary to the above-defined probes,detecting the complexes possibly formed between said probe and the nucleotide sequence of the HCV isolate to be identified.

REFERENCES:
patent: 5043272 (1991-08-01), Hartley
patent: 5077193 (1991-12-01), Mishiro et al.
patent: 5176994 (1993-01-01), Mishiro et al.
patent: 5252743 (1993-10-01), Barrett et al.
patent: 5372928 (1994-12-01), Miyamura et al.
patent: 5427909 (1995-06-01), Okamoto et al.
patent: 5428145 (1995-06-01), Okamoto et al.
patent: 5527669 (1996-06-01), Resnick et al.
patent: 5550016 (1996-08-01), Okamoto
patent: 5620852 (1997-04-01), Lin et al.
patent: 5629153 (1997-05-01), Urdea
patent: 5629158 (1997-05-01), Uhlen et al.
patent: 5846704 (1998-12-01), Maertens et al.
patent: 5871903 (1999-02-01), Miyamura et al.
patent: 6051696 (2000-04-01), Maertens et al.
patent: 6171784 (2001-01-01), Maertens et al.
patent: 6190864 (2001-02-01), Cha et al.
patent: 6297370 (2001-10-01), Cha et al.
patent: 6495670 (2002-12-01), Maertens et al.
patent: 6548244 (2003-04-01), Maertens et al.
patent: 0461863 (1991-12-01), None
patent: 0469348 (1992-02-01), None
patent: 529493 (1993-03-01), None
patent: 531974 (1999-12-01), None
patent: WO92/02642 (1992-02-01), None
patent: WO92/10588 (1992-06-01), None
patent: WO92/19743 (1992-11-01), None
patent: WO93/23569 (1993-11-01), None
Simmonds et al, J. of General Virology 74: 661-668 (1993).
Chan et al, J. of General Virology 73: 1131-1141 (1992).
Okamoto et al, J. of General Virology 7: 2697-2704 (1991).
Ogata et al, PNAS (USA) 88: 3392-3396 (1991).
Enomoto et al, Biochemical Biophysical Research Communications 170(3): 121-1025 (1990).
Choo et al, PNAS (USA) 88: 2451-2455 (1991).
Sommer et al. Nucleic Acids Research 17 (16):6749 (1989).
Takamizawa et al., J. of Virology 65 (3):1105-1113 (Mar. 1991).
Okamoto et al., Japanese J. of Experimental Medicine 60: 167-177 (1990).
Bukh et al., PNAS 89:4942-4946 (1992).
Okamoto et al., Virology 188:331-341 (1992).
Cha et al., PNAS 89:7144-7148 (1992).
Inchaupse et al., Hepatology 14: 595-600 (1991).
Weiner et al., Lancet 335: 1-3 (1990).
Lee et al., J. of Clinical Microbiology 30: 1602-1604 (1992).
Cha et al., J. of Clinical Microbiology 29(11):2528-2534 (1991).
Hu et al., J. Clin. Invest. 89, 2040-2045 (1992).
Nakao et al., J. of General Virology 72: 2105-2112 (1991).
Nedjar (1991) J. Virological Methods 35, 297-304.
Okamoto et al. (1992) J. Gen. Virol. 73:673-79.
Castillo et al. (1992) Journal of Virological Methods, vol. 38, No. 1, pp. 71-79.
Martell et al., J. of Virology 66(5): 3225-3229 (May 1992).
Stratagene Catalog, p. 39 (1988).
Okamoto et al, “The 5′-Terminal Sequence of the Hepatitis C Virus Genome”, Japanese Journal of Experimental Medicine, vol. 60, pp. 167-177, 1990.
Stuyver et al, “Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay”, Journal of General Virology (1993), vol. 74, pp. 1093-1102.
Press Release, Sep. 29, 2005, Innogenetics takes legal action to enforce its HCV patent portfolio.
“Expert Report of Bruce K. Patterson, M.D. Regarding the Invalidity of Innogenetics, N.V.'s U.S. Appl. No. 5,846,704”, signed Apr. 10, 2006 (33 pages with 14 page Exhibit A Curriculum Vitae, 2 page Exhibit B, 2 page Exhibit C, 2 page Exhibit D).
Complaint for patent infringement.Innogenetics V. Third Wave Technologies Inc., U.S. District Court For The Western District Of Wisconsin, Case No. 05C 0574 C, Filed Sep. 29, 2005 Filed Sep. 29, 2005.
TWT's Answer, Affirmative Defenses and Couterclaim,Innogenetics V. Technologies Inc., U.S. District Court for the Western District of Wisconsin, Case No. 05C 0574 C, Filed Sep. 29, 2005 Filed Sep. 29, 2005.
TWT's Supplemental Objections and Responses to Innogenetics' First Set of Interrogatories (No. 1-10); More Specifically See the List on pp.6-7. U.S. District Court for the Western District of Wisconsin, Case No. 05C 0574 C, Filed Sep. 29, 2005 Filed Sep. 29, 2005.
Plaintiff's Responses to Third Wave Technologies, Inc.'s First Set of Interrogatories (No. 1-11) to Innogenetics N.V.: See Specifically Response to No. 9. U.S. District Court for the Western District of Wisconsin, Case No. 05C 0574 C, Filed Sep. 29, 2005 Filed Sep. 29, 2005.
Stipulation and Order for Dismissal. U.S. District Court for the Western District of Wisconsin, Case No. 05C 0574 C. Filed Sep. 29, 2005.
Complaint - Summons Issued. U.S. District Court for the Western District of Wisconsin, Case No. 05C 0575 C. filed Sep. 29, 2005.
Answer U.S. District Court for the Western District of Wisconsin, Case No. 05C 0575 C, Filed Sep. 29, 2005.
Counterclaim and Affirmative Defenses of Deft. U.S. District Court for the Western District of Wisconsin, Case No. 05C 0575 C, Filed Sep. 29, 2005.
Plaintiff's Fisrt Set of Interrogatories U.S. District Court for the Western District of Wisconsin, Case No. 05C 0575 C, Filed Sep. 29, 2005.
Abbott's First Set of Interrogatories U.S. District Court for the Western District of Wisconsin, Case No. 05C 0575 C, Filed Sep. 29, 2005.
Abbott's First Set of Requests for Admission U.S. District Court for the Western District of Wisconsin, Case No. 05C 0575 C, Filed Sep. 29, 2005.
Answer to Counterclaim by Pltf. U.S. District Court for the Western District of Wisconsin, Case No. 05C 0575 C, Filed Sep. 29, 2005.
Abbot Laboratories' Answers to Innogentetics First Set of Interrogatories U.S. District Court for the Western District of Wisconsin, Case No. 05C 0575 C, Filed Sep. 29, 2005.
Plaintiff's Responses to Abbott Laboratories' First Set of Requests for Admission U.S. District Court for the Western District of Wisconsin, Case No. 05C 0575 C, Filed Sep. 29, 2005.
Plaintiff's Responses to Defendant Abbott Laboratories' First Set of Interrogatories U.S. District Court for the Western District of Wisconsin, Case No. 05C 0575 C, Filed Sep. 29, 2005.
Deposition of Charles A. Muserlian, Taken Jan, 11, 2006. (Muselian was the US corresponding attorney during prosecution for the '704 patent,) U.S. District Court for the Western District of Wisconsin, Case No. 05C 0574C & 05C 0575 C, Filed Sep. 29, 2005.
Plaintiffs Forst Set of Requests for Admission U.S. District Court for the Western District of Wisconsin, Case No. 05C 0575 C, Filed Sep. 29, 2005.
Abbott's First Supplemental Answers to Innogenetics' First Set of Interrogatories U.S. District Court for the Western District of Wisconsin, Case No. 05C 0575 C, Filed Sep. 29, 2005.
Abbott Laboratories' Motion to Compel Full and Complete Interrogatory Responses From Innogenetics, N.V. U.S. District Court for the Western District of Wisconsin, Case No. 05C 0575 C, Filed Sep. 29, 2005.
Abbott Laboratories'Brief in Support of its Motion to Compel Full and Complete Interrogatory Responses From Innogenetics, N.V. U.S. District Court for the Western District of Wisconsin, Case No. 05C 0575 C, Filed Sep. 29, 2005.
Brief in Opposition by Pltf. to Deft. Motion to Compel. U.S. District Court for the Western Disrtict of Wisconsin, Case No. 05C 0575 C, Filed Sep. 20, 2005.
Affidavit of Lissa R. Koop. U.S. District Court for the Western District of Winconsin, Case No. 05C 0574 C, Filed Sep. 29, 2005.
Abbott's Reply Brief in Support of its

Affiliated with

Also associated with

Rating

Process for typing of HCV isolates does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Process for typing of HCV isolates, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for typing of HCV isolates will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3884633